WebAptorum Group Limited (Nasdaq: APM) is a biopharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. …
DA:21PA:23MOZ Rank:100
Aptorum Group Ltd Announces Entering into an Agreement and …
WebNEW YORK & LONDON, March 06, 2024 -- ( BUSINESS WIRE )--Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company ( "Aptorum" ), and privately …
DA:42PA:49MOZ Rank:45
Aptorum Group Ltd Announces Entering into an Agreement and Plan of
Web1 year ago - Business Wire. Get a real-time Aptorum Group Limited (APM) stock price quote with breaking news, financials, statistics, charts and more. Market Cap: 49.17M Revenue (ttm): 1.20M Net Income (ttm): 13.40M Shares Out: 4.17M
Market Cap: 49.17M
Revenue (ttm): 1.20M
Net Income (ttm): 13.40M
Shares Out: 4.17M
DA:8PA:63MOZ Rank:4
Aptorum Group Announces Closing of $9.0 Million Public Offering
WebOct 2, 2020 · NEW YORK & LONDON & PARIS-- ( BUSINESS WIRE )--Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) (“Aptorum Group” or “Aptorum”), a …
DA:1PA:12MOZ Rank:30
Aptorum Group Limited (APM) Stock Price, News, Quote
WebAptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and …
DA:75PA:2MOZ Rank:97
Aptorum Group Limited Announces Closing of Initial Public …
WebDec 18, 2018 · HONG KONG-- ( BUSINESS WIRE )--Aptorum Group Limited (“Aptorum”, or the “Company”), a Hong Kong based pharmaceutical company currently in the …
DA:83PA:82MOZ Rank:56
Aptorum Group Limited Reports Financial Results and Business …
WebNEW YORK & LONDON, December 22, 2023--Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company …
DA:19PA:65MOZ Rank:11
Aptorum Group Limited Reports Financial Results and Business …
WebApr 12, 2024 · A high-level overview of Aptorum Group Limited (APM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …